Expression of B 7-H 4 and gastric cancer progression and prognosis : a meta-analysis

Background: Gastric cancer (GC) is one of the most common cancers worldwide. Some studies investigated the association between B7-H4 and GC prognosis. However, the results remained inconclusive. Thus, we performed a meta-analysis. Method: A comprehensive online search was conducted on Pubmed, Embase, Web of Science, Wanfan. The data were extracted by these two authors independently. The strength of association was assessed by calculating OR with 95% CI. Results: Six articles with 704 patients were enrolled in the present study. High expression of B7-H4 was associated with a significantly increased risk of undifferentiated GC (OR=1.72; 95% CI, 1.13-2.60; I2=0%), lymph node metastasis (OR=4.21; 95% CI, 2.63-6.75; I2=1%), high clinic stage (OR=4.00; 95% CI, 2.30-6.97; I2=47%), lymphatic invasion (OR=3.18; 95% CI, 1.58-6.38; I2=55%), venous invasion (OR=2.11; 95% CI, 1.12-3.95; I2=57%). However, B7-H4 did not associated with high T stage (OR=1.77; 95% CI, 0.85-3.68; I2=60%). High expression of B7-H4was associated with a significantly shorter overall survival (OS) of GC (OR=1.63; 95% CI, 1.30-2.03; I2=0%). Conclusion: This meta-analysis suggested that high B7-H4 expression might be associated with poor prognosis of GC.

[1]  Ling Wang,et al.  Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma , 2016, Tumor Biology.

[2]  Li-ke Yu,et al.  Evaluation of serum and pleural levels of soluble B7-H4 in lung cancer patients with pleural effusion , 2015, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[3]  Jingting Jiang,et al.  Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance , 2015, International Journal of Clinical Oncology.

[4]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[5]  T. Mak,et al.  B7-H4 Expression by Nonhematopoietic Cells in the Tumor Microenvironment Promotes Antitumor Immunity , 2014, Cancer Immunology Research.

[6]  Yan Li,et al.  Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis , 2014, Tumor Biology.

[7]  Qi Zhou,et al.  Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer , 2014, World Journal of Surgical Oncology.

[8]  Jun Sik Lee,et al.  Host B7x Promotes Pulmonary Metastasis of Breast Cancer , 2013, The Journal of Immunology.

[9]  J. Gribben,et al.  The role of B7 family molecules in hematologic malignancy. , 2013, Blood.

[10]  S. Natsugoe,et al.  Clinical Significance of the B7-H4 Coregulatory Molecule as a Novel Prognostic Marker in Gastric Cancer , 2011, World Journal of Surgery.

[11]  S. Natsugoe,et al.  Expression of B7‐H4 in blood of patients with gastric cancer predicts tumor progression and prognosis , 2010, Journal of surgical oncology.

[12]  Jingting Jiang,et al.  Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer , 2010, Cancer Immunology, Immunotherapy.

[13]  J. Cheville,et al.  Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family 1 , 2003, The Journal of Immunology.

[14]  G. Zhu,et al.  B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. , 2003, Immunity.

[15]  A. Neugut,et al.  Epidemiology of gastric cancer. , 2006, World journal of gastroenterology.

[16]  松永 知之.  Increased B7-H1 and B7-H4 expressions on circulating monocytes and tumor-associated macrophages are involved in immune evasion in patients with gastric cancer , 2011 .